(1)
Dong, K.; Wang, G.; Wang, Z. L.; Wang, X. Efficacy and Safety of Regorafenib Versus Dinutuximab With Chemotherapy in Chinese Children With Neuroblastoma. Bangladesh J Pharmacol 2019, 14, 32-35.